Reprogramming: identifying the mechanisms that safeguard cell identity

ABSTRACT Development and homeostasis rely upon concerted regulatory pathways to establish the specialized cell types needed for tissue function. Once a cell type is specified, the processes that restrict and maintain cell fate are equally important in ensuring tissue integrity. Over the past decade, several approaches to experimentally reprogram cell fate have emerged. Importantly, efforts to improve and understand these approaches have uncovered novel molecular determinants that reinforce lineage commitment and help resist cell fate changes. In this Review, we summarize recent studies that have provided insights into the various chromatin factors, post-transcriptional processes and features of genomic organization that safeguard cell identity in the context of reprogramming to pluripotency. We also highlight how these factors function in other experimental, physiological and pathological cell fate transitions, including direct lineage conversion, pluripotency-to-totipotency reversion and cancer. Summary: Recent work has characterized barriers to cell fate change. This Review explores the possibility that these barriers play a role during alternative cell fate transitions as well as in tumorigenesis.

[1]  H. Snoeck Calcium regulation of stem cells , 2020, EMBO reports.

[2]  Sexually Mature , 2020, Definitions.

[3]  R. Sridharan,et al.  Coordinated removal of repressive epigenetic modifications during induced reversal of cell identity , 2019, The EMBO journal.

[4]  J. Brumbaugh,et al.  Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo , 2019, Nature Cell Biology.

[5]  L. Morey,et al.  Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer. , 2019, Trends in biochemical sciences.

[6]  Xudong Fu,et al.  Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells , 2019, Nature Cell Biology.

[7]  S. Orkin,et al.  Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNA. , 2019, Molecular cell.

[8]  R. Jaenisch,et al.  Hominoid-Specific Transposable Elements and KZFPs Facilitate Human Embryonic Genome Activation and Control Transcription in Naive Human ESCs , 2019, Cell stem cell.

[9]  E. Wagner,et al.  Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation. , 2019, The Journal of clinical investigation.

[10]  Yi Zhang,et al.  Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development , 2019, Nature Genetics.

[11]  Liang Ming,et al.  The role of m6A RNA methylation in cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  K. Zaret,et al.  Role of H3K9me3 heterochromatin in cell identity establishment and maintenance. , 2019, Current opinion in genetics & development.

[13]  Q. Lan,et al.  The Critical Role of RNA m6A Methylation in Cancer. , 2019, Cancer research.

[14]  J. Hanna,et al.  Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation , 2019, Nature Cell Biology.

[15]  Qiang Wu,et al.  Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer. , 2019, American journal of translational research.

[16]  Zhike Lu,et al.  Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally , 2019, Nature.

[17]  Jason D. Buenrostro,et al.  Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules. , 2019, Cell stem cell.

[18]  A. Dejean,et al.  SUMO Safeguards Somatic and Pluripotent Cell Identities by Enforcing Distinct Chromatin States. , 2018, Cell stem cell.

[19]  S. Heath,et al.  Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate. , 2018, Cell stem cell.

[20]  A. Shilatifard,et al.  A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis. , 2018, Cancer cell.

[21]  F. Supek,et al.  Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours , 2018, Nature Cell Biology.

[22]  B. Aronow,et al.  H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression , 2018, Nature Communications.

[23]  L. Tsang,et al.  R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells , 2018, Cancer Cell International.

[24]  R. Sridharan,et al.  The role of α-ketoglutarate–dependent proteins in pluripotency acquisition and maintenance , 2018, The Journal of Biological Chemistry.

[25]  Jason D. Buenrostro,et al.  Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency. , 2018, Cell stem cell.

[26]  S. Lacadie,et al.  FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells , 2018, Developmental cell.

[27]  T. Swigut,et al.  Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation , 2018, eLife.

[28]  Xiaohua Shen,et al.  A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity , 2018, Cell.

[29]  O. Klein,et al.  Parasitic helminthes induce fetal-like reversion in the intestinal stem cell niche , 2018, Nature.

[30]  O. Klein,et al.  Parasitic helminthes induce fetal-like reversion in the intestinal stem cell niche , 2018, Nature.

[31]  J. Polo,et al.  SRSF3 promotes pluripotency through Nanog mRNA export and coordination of the pluripotency gene expression program , 2018, eLife.

[32]  F. Sotgia,et al.  Cancer stem cells (CSCs): metabolic strategies for their identification and eradication , 2018, The Biochemical journal.

[33]  G. Pfeifer Defining Driver DNA Methylation Changes in Human Cancer , 2018, International journal of molecular sciences.

[34]  K. Somasundaram,et al.  Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance , 2018, Oncogene.

[35]  Katie J. Clowers,et al.  Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling , 2018, Cell.

[36]  Xiaohui S. Xie,et al.  Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. , 2018, Molecular cell.

[37]  B. Garcia,et al.  Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes. , 2017, Molecular cell.

[38]  Juan M. Vaquerizas,et al.  A molecular roadmap for the emergence of early-embryonic-like cells in culture , 2017, Nature Genetics.

[39]  C. Mayr Regulation by 3'-Untranslated Regions. , 2017, Annual review of genetics.

[40]  Jennifer E. Phillips-Cremins,et al.  Crossed wires: 3D genome misfolding in human disease , 2017, The Journal of cell biology.

[41]  Stefan Mundlos,et al.  The three-dimensional genome: regulating gene expression during pluripotency and development , 2017, Development.

[42]  K. Hochedlinger,et al.  Emerging roles of the histone chaperone CAF-1 in cellular plasticity. , 2017, Current opinion in genetics & development.

[43]  H. Bourbon,et al.  Genome Regulation by Polycomb and Trithorax: 70 Years and Counting , 2017, Cell.

[44]  Wei Zhao,et al.  USP26 functions as a negative regulator of cellular reprogramming by stabilising PRC1 complex components , 2017, Nature Communications.

[45]  G. Laible,et al.  KDM4B-mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency , 2017, Scientific Reports.

[46]  Yuval Kluger,et al.  m6A mRNA methylation controls T cell homeostasis by targeting IL-7/STAT5/SOCS pathway , 2017, Nature.

[47]  Olivier Elemento,et al.  Stem Cell Lineage Infidelity Drives Wound Repair and Cancer , 2017, Cell.

[48]  S. Tapscott,et al.  Conserved roles for murine DUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons , 2017, Nature Genetics.

[49]  Javier Quilez,et al.  Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming , 2017, Nature Genetics.

[50]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[51]  Chuan He,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[52]  Chunhui Hou,et al.  RNA Helicase DDX5 Inhibits Reprogramming to Pluripotency by miRNA-Based Repression of RYBP and its PRC1-Dependent and -Independent Functions. , 2017, Cell stem cell.

[53]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[54]  L. Fiette,et al.  Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle. , 2017, Cell stem cell.

[55]  Dylan M. Marchione,et al.  Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas , 2017, Nature Genetics.

[56]  C. R. Esteban,et al.  In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming , 2016, Cell.

[57]  D. Mager,et al.  Endogenous retroviral promoter exaptation in human cancer , 2016, Mobile DNA.

[58]  M. Blasco,et al.  Tissue damage and senescence provide critical signals for cellular reprogramming in vivo , 2016, Science.

[59]  C. Feschotte,et al.  Regulatory activities of transposable elements: from conflicts to benefits , 2016, Nature Reviews Genetics.

[60]  I. Petersen,et al.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking , 2016, Nature Genetics.

[61]  J. García-Pérez,et al.  The impact of transposable elements on mammalian development , 2016, Development.

[62]  B. Bonev,et al.  Organization and function of the 3D genome , 2016, Nature Reviews Genetics.

[63]  B. Tian,et al.  Alternative polyadenylation of mRNA precursors , 2016, Nature Reviews Molecular Cell Biology.

[64]  M. Boutros,et al.  Wnt signaling in cancer , 2016, Oncogene.

[65]  Jianlong Wang,et al.  Zfp281 Coordinates Opposing Functions of Tet1 and Tet2 in Pluripotent States. , 2016, Cell stem cell.

[66]  Salvador Aznar Benitah,et al.  Epigenetic control of adult stem cell function , 2016, Nature Reviews Molecular Cell Biology.

[67]  Wouter de Laat,et al.  The second decade of 3C technologies: detailed insights into nuclear organization , 2016, Genes & development.

[68]  Howard Cedar,et al.  DNA Methylation in Cancer and Aging. , 2016, Cancer research.

[69]  Lei S. Qi,et al.  CRISPR/Cas9 in Genome Editing and Beyond. , 2016, Annual review of biochemistry.

[70]  S. Thibodeau,et al.  The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas , 2016, Science.

[71]  B. Garcia,et al.  Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape , 2016, Science.

[72]  Thomas G. Gilgenast,et al.  Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming. , 2016, Cell stem cell.

[73]  Peter H. L. Krijger,et al.  Cell-of-Origin-Specific 3D Genome Structure Acquired during Somatic Cell Reprogramming , 2016, Cell stem cell.

[74]  B. Cieply,et al.  Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins. , 2016, Cell reports.

[75]  T. Pandita,et al.  The many faces of histone H3K79 methylation. , 2016, Mutation research. Reviews in mutation research.

[76]  K. Helin,et al.  Role of TET enzymes in DNA methylation, development, and cancer , 2016, Genes & development.

[77]  Brian D. Bennett,et al.  A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 , 2016, Stem cell reports.

[78]  Greg G. Wang,et al.  Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. , 2016, Cell stem cell.

[79]  Alexander van Oudenaarden,et al.  Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. , 2016, Cell stem cell.

[80]  P. Ordóñez-Morán,et al.  Polycomb Complex PRC1 Preserves Intestinal Stem Cell Identity by Sustaining Wnt/β-Catenin Transcriptional Activity. , 2016, Cell stem cell.

[81]  Shawn M. Gillespie,et al.  Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.

[82]  Howard Y. Chang,et al.  The histone chaperone CAF-1 safeguards somatic cell identity , 2015, Nature.

[83]  Dong Ryul Lee,et al.  Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells. , 2015, Cell stem cell.

[84]  Rong Wang,et al.  Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming. , 2015, Cell stem cell.

[85]  Daniel S. Day,et al.  Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.

[86]  George Q. Daley,et al.  Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells , 2015, Cell.

[87]  Wei Li,et al.  NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation , 2015, eLife.

[88]  Juan M. Vaquerizas,et al.  Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly , 2015, Nature Structural &Molecular Biology.

[89]  Chuan He,et al.  RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation , 2015, Genes & development.

[90]  A. Visel,et al.  Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions , 2015, Cell.

[91]  Qi Zhou,et al.  m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. , 2015, Cell stem cell.

[92]  D. Fan,et al.  The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. , 2015, Current pharmaceutical design.

[93]  Erez Y. Levanon,et al.  m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation , 2015, Science.

[94]  Jing Liang,et al.  Chromatin architecture reorganization during stem cell differentiation , 2015, Nature.

[95]  C. Allis,et al.  Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.

[96]  Yi Xing,et al.  m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. , 2014, Cell stem cell.

[97]  M. Zenke,et al.  Pcgf6, a Polycomb Group Protein, Regulates Mesodermal Lineage Differentiation in Murine ESCs and Functions in iPS Reprogramming , 2014, Stem cells.

[98]  Shogo Matoba,et al.  Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation , 2014, Cell.

[99]  L. Hurst,et al.  Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells , 2014, Nature.

[100]  A. Tsirigos,et al.  Combinatorial Modulation of Signaling Pathways Reveals Cell-Type-Specific Requirements for Highly Efficient and Synchronous iPSC Reprogramming , 2014, Stem cell reports.

[101]  S. Ramaswamy,et al.  Small molecules facilitate rapid and synchronous iPSC generation , 2014, Nature Methods.

[102]  H. Otu,et al.  Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming , 2014, Science.

[103]  W. Paschen,et al.  SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development , 2014, EMBO reports.

[104]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[105]  A. Radzisheuskaya,et al.  MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner , 2014, Cell stem cell.

[106]  Wolfgang Huber,et al.  Enhancer loops appear stable during development and are associated with paused polymerase , 2014, Nature.

[107]  B. Ren,et al.  The 3D genome in transcriptional regulation and pluripotency. , 2014, Cell stem cell.

[108]  Gad Getz,et al.  Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing , 2014, Genome research.

[109]  Wei Li,et al.  CFIm25 links Alternative Polyadenylation to Glioblastoma Tumor Suppression , 2014, Nature.

[110]  Martin S. Taylor,et al.  Long interspersed element-1 protein expression is a hallmark of many human cancers. , 2014, The American journal of pathology.

[111]  S. Baylin,et al.  The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes , 2014, Oncogene.

[112]  Xiaohui S. Xie,et al.  Fip1 regulates mRNA alternative polyadenylation to promote stem cell self‐renewal , 2014, The EMBO journal.

[113]  Britta A. M. Bouwman,et al.  A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia , 2014, Cell.

[114]  W. Liu,et al.  Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. , 2014, Cell stem cell.

[115]  S. Yamanaka,et al.  Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.

[116]  S. Orkin,et al.  Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. , 2014, Cell stem cell.

[117]  Denis Thieffry,et al.  C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells , 2013, Nature.

[118]  Matteo Pellegrini,et al.  Long-range chromatin contacts in embryonic stem cells reveal a role for pluripotency factors and polycomb proteins in genome organization. , 2013, Cell stem cell.

[119]  Benjamin D. Medoff,et al.  Dedifferentiation of committed epithelial cells into stem cells in vivo , 2013, Nature.

[120]  S. Yamanaka,et al.  Global splicing pattern reversion during somatic cell reprogramming. , 2013, Cell reports.

[121]  K. Hochedlinger,et al.  Chromatin dynamics during cellular reprogramming , 2013, Nature.

[122]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[123]  M. Serrano,et al.  Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.

[124]  I. Grummt,et al.  NuRD Blocks Reprogramming of Mouse Somatic Cells into Pluripotent Stem Cells , 2013, Stem cells.

[125]  Bruno Di Stefano,et al.  Polycomb complexes in stem cells and embryonic development , 2013, Development.

[126]  B. Garcia,et al.  Proteomic and genomic approaches reveal critical functions of H3K9 methylation and Heterochromatin Protein-1γ in reprogramming to pluripotency , 2013, Nature Cell Biology.

[127]  Jennifer E. Phillips-Cremins,et al.  Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment , 2013, Cell.

[128]  Francesco Ferrari,et al.  Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. , 2013, Cell stem cell.

[129]  Eric T. Wang,et al.  MBNL proteins repress ES-cell-specific alternative splicing and reprogramming , 2013, Nature.

[130]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[131]  D. Koh,et al.  The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation , 2013, Nucleic acids research.

[132]  G. Viglietto,et al.  Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells. , 2013, Blood.

[133]  Samir Karaca,et al.  Detecting endogenous SUMO targets in mammalian cells and tissues , 2013, Nature Structural &Molecular Biology.

[134]  K. Helin,et al.  Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation , 2013, Nature Cell Biology.

[135]  B. Garcia,et al.  MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency , 2013, Nature Communications.

[136]  R. Russell,et al.  Intestinal label-retaining cells are secretory precursors expressing Lgr5 , 2013, Nature.

[137]  Zachary D. Smith,et al.  DNA methylation: roles in mammalian development , 2013, Nature Reviews Genetics.

[138]  G. Pruneri,et al.  Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets , 2013, PLoS genetics.

[139]  W. Reik,et al.  Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency , 2013, Nature.

[140]  P. Arlotta,et al.  Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo , 2013, Nature Cell Biology.

[141]  Jieying Zhu,et al.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs , 2012, Nature Genetics.

[142]  Yongsheng Shi,et al.  Alternative polyadenylation: new insights from global analyses. , 2012, RNA.

[143]  Greg Donahue,et al.  Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome , 2012, Cell.

[144]  S. González,et al.  Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. , 2012, Cell stem cell.

[145]  E. Ballestar,et al.  Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells. , 2012, Molecular cell.

[146]  Thomas Vierbuchen,et al.  Molecular roadblocks for cellular reprogramming. , 2012, Molecular cell.

[147]  A. Oudenaarden,et al.  Dll1+ secretory progenitor cells revert to stem cells upon crypt damage , 2012, Nature Cell Biology.

[148]  Sandy L. Klemm,et al.  Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase , 2012, Cell.

[149]  G. Bhagat,et al.  Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2 , 2012, Nature.

[150]  Muneef Ayyash,et al.  The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming , 2012, Nature.

[151]  Shawn P. Driscoll,et al.  ES cell potency fluctuates with endogenous retrovirus activity , 2012, Nature.

[152]  Xiaoxia Qi,et al.  Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.

[153]  J. Sedat,et al.  Spatial partitioning of the regulatory landscape of the X-inactivation centre , 2012, Nature.

[154]  Jesse R. Dixon,et al.  Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.

[155]  M. Surani,et al.  Epiblast Stem Cell-Based System Reveals Reprogramming Synergy of Germline Factors , 2012, Cell stem cell.

[156]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[157]  Tom H. Cheung,et al.  Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. , 2012, Cell stem cell.

[158]  Eric S. Lander,et al.  Chromatin modifying enzymes as modulators of reprogramming , 2012, Nature.

[159]  A. Iwama,et al.  Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. , 2011, Blood.

[160]  G. Pan,et al.  The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. , 2011, Cell stem cell.

[161]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[162]  Li Qian,et al.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.

[163]  Jeffrey L. Wrana,et al.  An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.

[164]  R. Young,et al.  Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage. , 2011, Cell stem cell.

[165]  R. Shiekhattar,et al.  Jarid2 regulates mouse epidermal stem cell activation and differentiation , 2011, The EMBO journal.

[166]  Lars Bullinger,et al.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.

[167]  P. Wade,et al.  Cancer biology and NuRD: a multifaceted chromatin remodelling complex , 2011, Nature Reviews Cancer.

[168]  Emily Bernstein,et al.  Stem cells and reprogramming: breaking the epigenetic barrier? , 2011, Trends in pharmacological sciences.

[169]  A. Gillich,et al.  Histone variant macroH2A confers resistance to nuclear reprogramming , 2011, The EMBO journal.

[170]  Jonathan M. Monk,et al.  Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network , 2011, Cell.

[171]  Paul Tempst,et al.  PRC2 Complexes with JARID2, MTF2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprograming , 2011, Stem cells.

[172]  Oliver Hobert,et al.  Direct Conversion of C. elegans Germ Cells into Specific Neuron Types , 2011, Science.

[173]  A. Behrens,et al.  c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex , 2011, Nature.

[174]  G. Mizuguchi,et al.  Stepwise Histone Replacement by SWR1 Requires Dual Activation with Histone H2A.Z and Canonical Nucleosome , 2010, Cell.

[175]  Krishanu Saha,et al.  Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.

[176]  B. Garcia,et al.  The histone variant macroH2A suppresses melanoma progression through regulation of CDK8 , 2010, Nature.

[177]  K. Hochedlinger,et al.  Induced pluripotency: history, mechanisms, and applications. , 2010, Genes & development.

[178]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[179]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[180]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[181]  H. Blau,et al.  Nuclear reprogramming to a pluripotent state by three approaches , 2010, Nature.

[182]  T. Pawson,et al.  Post-translational modifications in signal integration , 2010, Nature Structural &Molecular Biology.

[183]  Alexander R. Pico,et al.  Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation , 2010, Proceedings of the National Academy of Sciences.

[184]  Ralph Stadhouders,et al.  Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma , 2010, Nature Medicine.

[185]  A. Iwama,et al.  Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. , 2010, Cell stem cell.

[186]  Z. Nagy,et al.  Rapid elimination of the histone variant MacroH2A from somatic cell heterochromatin after nuclear transfer. , 2010, Cellular reprogramming.

[187]  H. Redl,et al.  Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.

[188]  T. Hothorn,et al.  Histone macroH2A isoforms predict the risk of lung cancer recurrence , 2009, Oncogene.

[189]  Gene W. Yeo,et al.  L1 retrotransposition in human neural progenitor cells , 2009, Nature.

[190]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[191]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[192]  M. Blasco,et al.  The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.

[193]  J. Utikal,et al.  Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.

[194]  G. Wahl,et al.  Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.

[195]  Suchit Jhunjhunwala,et al.  Chromatin Architecture and the Generation of Antigen Receptor Diversity , 2009, Cell.

[196]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[197]  J. Nichols,et al.  Naive and primed pluripotent states. , 2009, Cell stem cell.

[198]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[199]  J. Nichols,et al.  Klf4 reverts developmentally programmed restriction of ground state pluripotency , 2009, Development.

[200]  G. Hannon,et al.  Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells , 2009, Cell.

[201]  K. Hochedlinger,et al.  Epigenetic reprogramming and induced pluripotency , 2009, Development.

[202]  D. Melton,et al.  Nuclear Reprogramming in Cells , 2008, Science.

[203]  H. Cedar,et al.  De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes , 2008, Nature Structural &Molecular Biology.

[204]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[205]  Eric S. Lander,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[206]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[207]  R. Jaenisch,et al.  Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice , 2008, Oncogene.

[208]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[209]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[210]  T. Graf Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[211]  E. Li,et al.  Synergistic Function of DNA Methyltransferases Dnmt3a and Dnmt3b in the Methylation of Oct4 and Nanog , 2007, Molecular and Cellular Biology.

[212]  M. Trotter,et al.  Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.

[213]  R. McKay,et al.  New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.

[214]  S. Yamanaka Strategies and new developments in the generation of patient-specific pluripotent stem cells. , 2007, Cell stem cell.

[215]  W. Reik Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[216]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[217]  R. Jaenisch,et al.  Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus , 2006, Stem cells.

[218]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[219]  Andrew P Feinberg,et al.  The epigenetics of cancer etiology. , 2004, Seminars in cancer biology.

[220]  T. Chevassut,et al.  Severe Global DNA Hypomethylation Blocks Differentiation and Induces Histone Hyperacetylation in Embryonic Stem Cells , 2004, Molecular and Cellular Biology.

[221]  H. Lauke,et al.  Cell Type-specific Expression of LINE-1 Open Reading Frames 1 and 2 in Fetal and Adult Human Tissues* , 2004, Journal of Biological Chemistry.

[222]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[223]  S. Morrison,et al.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.

[224]  E. Li,et al.  Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b , 2003, Molecular and Cellular Biology.

[225]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[226]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[227]  Karl Mechtler,et al.  Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability , 2001, Cell.

[228]  A. Wolffe,et al.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[229]  B. Stillman,et al.  Heterochromatin dynamics in mouse cells: interaction between chromatin assembly factor 1 and HP1 proteins. , 1999, Molecular cell.

[230]  I. Wilmut,et al.  Sheep cloned by nuclear transfer from a cultured cell line , 1996, Nature.

[231]  M. Sofroniew,et al.  Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.

[232]  P. Donovan,et al.  Long-term proliferation of mouse primordial germ cells in culture , 1992, Nature.

[233]  B. Hogan,et al.  Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture , 1992, Cell.

[234]  K. Kinzler,et al.  Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. , 1992, Cancer research.

[235]  B. Stillman,et al.  Purification and characterization of CAF-I, a human cell factor required for chromatin assembly during DNA replication in vitro , 1989, Cell.

[236]  J. Spandorfer,et al.  Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma , 1988, Nature.

[237]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[238]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[239]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[240]  T. Elsdale,et al.  Sexually Mature Individuals of Xenopus laevis from the Transplantation of Single Somatic Nuclei , 1958, Nature.

[241]  C. Collins,et al.  SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. , 2017, European urology.

[242]  C. Pilarsky,et al.  The EMT-activator Zeb 1 is a key factor for cell plasticity and promotes metastasis in 1 pancreatic cancer 2 , 2017 .

[243]  K. Zaret,et al.  H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes. , 2016, Trends in genetics : TIG.

[244]  M. Rauchman,et al.  The nucleosome remodeling and deacetylase complex in development and disease. , 2015, Translational research : the journal of laboratory and clinical medicine.

[245]  M. Esteller,et al.  DNA methylation and cancer. , 2010, Advances in genetics.

[246]  L. Allen Stem cells. , 2003, The New England journal of medicine.